CSF I+/--synuclein concentrations do not fluctuate over hours and are not correlated to amyloid I super(2) in humans
Reports on the value of cerebrospinal fluid (CSF) I+/--synuclein as a biomarker for dementia with Lewy bodies and Parkinson disease are contradicting. This may be explained by fluctuating CSF I+/--synuclein concentrations over time. Such fluctuations have been suggested for CSF amyloid I super(2) co...
Saved in:
Published in: | Neuroscience letters Vol. 504; no. 3; pp. 336 - 338 |
---|---|
Main Authors: | , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
31-10-2011
|
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Reports on the value of cerebrospinal fluid (CSF) I+/--synuclein as a biomarker for dementia with Lewy bodies and Parkinson disease are contradicting. This may be explained by fluctuating CSF I+/--synuclein concentrations over time. Such fluctuations have been suggested for CSF amyloid I super(2) concentrations. Furthermore, a physiological relationship between I+/--synuclein and amyloid I super(2) has been suggested based on in vitro research. We performed repeated CSF sampling in healthy elderly and AD patients and showed that sinusoidal fluctuations in CSF I+/--synuclein concentrations were not present. Furthermore, we did not find evidence for an interaction between amyloid I super(2) and I+/--synuclein concentrations in CSF. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 content type line 23 ObjectType-Feature-1 |
ISSN: | 0304-3940 |
DOI: | 10.1016/j.neulet.2011.09.063 |